Related Experiment Video
Updated: May 5, 2026

07:45
"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach
Published on: November 28, 2025
284
Reoperative experience with papillary thyroid cancer
Edwin O Onkendi1, Travis J McKenzie, Melanie L Richards
1Department of Surgery, Mayo Clinic, Rochester, MN, USA.
World Journal of Surgery
|December 6, 2013
Summary
Reoperation for recurrent papillary thyroid cancer (PTC) can achieve disease-free status in 72% of patients. However, nearly 40% experience further relapse, highlighting the need for improved surgical techniques and preoperative localization for recurrent PTC.
Area of Science:
- Oncology
- Surgical Oncology
- Endocrine Surgery
Background:
- Intense postoperative monitoring increases detection of recurrent papillary thyroid cancer (PTC).
- Reoperation is a key strategy for managing PTC recurrence.
- Understanding outcomes and complications of reoperation is crucial.
Purpose of the Study:
- To quantify the success of reoperation for recurrent PTC.
- To analyze surgical complications associated with reoperation.
- To identify reasons for disease relapse after reoperation.
Main Methods:
- A retrospective analysis of 410 patients undergoing reoperation for PTC relapse from 1999 to 2008.
- Detailed analysis of surgical procedures performed, including thyroidectomy, node dissection, and recurrence excision.
- Evaluation of post-reoperative disease outcomes, complications, and reasons for relapse.
Main Results:
- Reoperation involved various procedures like thyroidectomy, node dissection (levels II-VI), and recurrence excision.
- Complications occurred in 6% of patients, including hypoparathyroidism (3%) and recurrent laryngeal nerve paralysis (3%).
- Of 380 patients with follow-up, 72% were disease-free, 38% relapsed, 11% died from PTC, and 14% were alive with disease.
Conclusions:
- Reoperation successfully rendered 72% of patients disease-free, but nearly 40% relapsed.
- Reasons for relapse included false-negative ultrasounds, nodal recurrence, and disease aggressiveness.
- Improved surgical techniques and preoperative localization could potentially improve outcomes for 15-20% of patients.

